Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT04320628 Completed - Chronic Wounds Clinical Trials

Randomized Double-Blind Controlled Clinical Trial

Start date: May 20, 2020
Phase: N/A
Study type: Interventional

The study is a randomized double-blind controlled clinical trial designed to compare the ability of NaOCl to NSS in the reduction of bacterial burden in nonhealing acute and chronic wounds.

NCT ID: NCT04318665 Completed - Clinical trials for Traumatic Brain Injury

Early Diagnosis of Mortality Using Admission CT Perfusion in Severe Traumatic Brain Injury Patients (ACT-TBI Study)

ACT-TBI
Start date: July 23, 2020
Phase: N/A
Study type: Interventional

Background: Severe traumatic brain injury (TBI) is a principal cause of post-injury hospitalization, disability, and death throughout the world. TBI is the leading cause of death and disability among young healthy people under 45 years of age and is predicted to be the most prevalent and costliest neurological condition in Canada through the year 2031. TBI is commonly classified into mild, moderate, and severe categories using the Glasgow Coma Scale (GCS), with "severe TBI" defined as a GCS score ≤ 8. Severe TBI is a clinical emergency, during which the trauma team works swiftly to provide the appropriate care. Outcome assessment after TBI is complex and is influenced by pre-injury and injury factors as well as the patient's response at various stages of recovery. The first 48 hrs in hospital, despite being the most resource-intensive period, unfortunately result in the highest mortality. These patients are on life support at the time of their hospital admission and adequate and reliable clinical examination is impossible. Thus, patients receive treatment despite lack of a clear understanding of their prognoses. Hypothesis: Admission Computed Tomographic Perfusion (CTP) can diagnose brain death reliably in severe TBI patients in early stage upon hospital admission, which is not recognised in the usual clinical practice due to inadequate reliable clinical examination. In a small prospective pilot study of 19 patients with severe TBI, admission CTP could predict early in hospital mortality with 75% sensitivity, 100% specificity, 100% positive predictive value (PPV) and 94% negative predictive value (NPV) and perfect inter-rater reliability (kappa=1). We propose ACT-TBI study to evaluate CTP as a triage tool to diagnose early mortality at the time of admission in patients with severe TBI. Primary Objective: To validate admission CTP features of brain death, relative to the clinical examination outcome, for characterizing early in-hospital mortality. Secondary objectives: To establish the safety and interrater reliability of admission CTP.

NCT ID: NCT04318496 Completed - Rib Fractures Clinical Trials

Acupuncture for Blunt Chest Trauma

Start date: March 23, 2020
Phase: N/A
Study type: Interventional

Introduction: Chest blunt trauma accounts in up to 65% of polytrauma patients. In patients with 0-2 rib fracture, the treatment is relatively limited to oral pain killer and breathing exercise. The patients will suffer two weeks of severe pain accompanied with poor sleep and inability to preform simple daily live activities. In this double blind randomized control study, the investigators offer acupuncture as an additional treatment option. Methods: The study is a double blind randomized control trial. the study will include the press needle acupuncture (Acu) and placebo (Con) group. Both groups will receive one treatment, following the first visit to the clinic after chest trauma accident.

NCT ID: NCT04316299 Completed - COVID-19 Clinical Trials

Acute Kidney Injury in Patients Hospitalized With COVID-19

Start date: February 26, 2020
Phase:
Study type: Observational

The kidney may be affected in coronavirus-2019 disease (COVID-19). This study assessed the predictors and outcomes of acute kidney injury (AKI) among individuals with COVID-19.

NCT ID: NCT04315389 Completed - Stroke Clinical Trials

SG Healthcare and Assistive Robotics Programme (SHARP) - Proof of Concept Study

SHARPCARE
Start date: December 2, 2020
Phase:
Study type: Observational

Robots are commonly used in many settings to help with transportation needs, reduce human injuries, and assisting clinicians during surgeries. These applications could provide direct benefits to patients in the clinical rehabilitation field. In this study, the feasibility of 2 CARE robot prototypes in facilitating dependent transfers and assisting patient mobility in their daily living activities will be studied.

NCT ID: NCT04312958 Completed - Trauma Clinical Trials

Quantra QStat in Trauma and Liver Transplant

Start date: July 20, 2020
Phase:
Study type: Observational

This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.

NCT ID: NCT04310956 Completed - Ligament Injury Clinical Trials

A RCT for Y-Knot All-suture Anchor in Ankle Ligaments Injury Repair

Start date: December 23, 2019
Phase: N/A
Study type: Interventional

Purpose of this study is to evaluate the effectiveness and safety of Y-Knot all-suture anchor by comparing patients' clinical outcome after ankle ligaments repair surgery.

NCT ID: NCT04310280 Completed - Wound Healing Clinical Trials

Effects of Local Insulin on Varicose Ulcers for Wound Healing

Start date: June 1, 2019
Phase: Phase 3
Study type: Interventional

A randomized, split-plot, double-blind, placebo-controlled trial. The varicose ulcer is divided into two (side A and B). Half of the wound's surface is treated locally with insulin (Glargine) applied at an approx depth of 3-4 mm. Treatment with insulin is administered for 7 days. Biopsy specimens of the two sides are obtained on days 0 and 7. A thermographic photograph of the wound is taken at days 0 and 7. The number of blood vessels and fibroplasia is evaluated as the main outcome.

NCT ID: NCT04308577 Completed - Stroke Clinical Trials

Diet Induced Ketosis for Brain Injury - A Feasibility Study

Start date: October 5, 2020
Phase: N/A
Study type: Interventional

Each year, approx. 100 patients with severe brain injury is admitted to the Clinic for Neurorehabilitation/TBI Unit, Rigshospitalet. Severe brain injury results in local oxygen deficiency and acid formation in the brain, which together destroys brain cells. The purpose of this study is to investigate whether it is possible to carry out a ketogenic diet therapy for patients with severe brain injury for six weeks. Ketosis has been shown to be neuroprotective during and after severe brain injury.

NCT ID: NCT04306601 Completed - Clinical trials for Traumatic Brain Injury With Prolonged Loss of Consciousness

Low-Intensity Focused Ultrasound on Individuals With Disorder of Consciousness of Traumatic Brain Injury

Start date: June 25, 2020
Phase: N/A
Study type: Interventional

Low-intensity focused ultrasound can be effective in severe TBI patients with disorder of consciousness. This study is a prospective single arm, open-label and explorative clinical trial to evaluate the therapeutic effect of recovery from DoC and safety of low-intensity focused ultrasound stimulation at thalamic area in patients with post-traumatic DoC.